CORESTEMCHEMON Inc.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Price
Change
Market cap
Products & technology
- Neuronata-RALS (amyotrophic lateral sclerosis) treatment
Regulatory approvals
data.go.kr1 Korean MFDS drug approvals · 2021
- MFDS drugNeuronata-R®inj.2021-08-27Drug · Prescription · Approval202106193
Clinical trials
data.go.kr7 MFDS clinical trial authorisations · 2015–2024 (Phase 1 6 · Phase 3 1)
- Phase 1CE211NS212024-06-05
5 trial sites
- Phase 1뉴로나타-알주2022-08-05
2 trial sites
- Phase 1CS10BR052018-04-20
1 trial site
- Phase 1CS20AT042017-07-17
1 trial site
- Phase 1CS10BR052016-06-09
1 trial site
- Phase 1CS20AT042015-05-06
1 trial site
- Phase 3뉴로나타-알주2015-04-17
5 trial sites
R&D and key agreements
Source: DART corporate disclosure2세대(차세대) 줄기세포치료제 · 희귀·난치성질환 · 기초연구·공정자동화기술 연구개발중 · Developing new stem cell therapies for rare and intractable diseases, with basic research on second-generation stem cell therapies and process automation technology under way.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition